211 related articles for article (PubMed ID: 17261762)
1. Selective estrogen receptor modulators and phytoestrogens.
Oseni T; Patel R; Pyle J; Jordan VC
Planta Med; 2008 Oct; 74(13):1656-65. PubMed ID: 18843590
[TBL] [Abstract][Full Text] [Related]
2. The 4Ps of Breast Cancer Chemoprevention: Putting Proven Principles into Practice.
Jordan VC
Cancer Prev Res (Phila); 2017 Apr; 10(4):219-222. PubMed ID: 28246081
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review.
Oceguera-Basurto P; Topete A; Oceguera-Villanueva A; Rivas-Carrillo J; Paz-Davalos M; Quintero-Ramos A; Del Toro-Arreola A; Daneri-Navarro A
Transl Cancer Res; 2020 Jul; 9(7):4444-4456. PubMed ID: 35117809
[TBL] [Abstract][Full Text] [Related]
4. Statins and Breast Cancer: Future Directions in Chemoprevention.
Santa-Maria CA; Stearns V
Curr Breast Cancer Rep; 2013 Sep; 5(3):161-169. PubMed ID: 23997864
[TBL] [Abstract][Full Text] [Related]
5. SERM Therapy for patients of breast cancer and otherwise.
Sikandar E; Javid A; Ahmed M
J Pak Med Assoc; 2024 Jan; 74(1):200. PubMed ID: 38219209
[No Abstract] [Full Text] [Related]
6. Correction to: Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy.
J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38719203
[No Abstract] [Full Text] [Related]
7. BCPT 2023 policy for experimental and clinical studies.
Tveden-Nyborg P; Bergmann TK; Jessen N; Simonsen U; Lykkesfeldt J
Basic Clin Pharmacol Toxicol; 2023 Oct; 133(4):391-396. PubMed ID: 37732406
[No Abstract] [Full Text] [Related]
8. Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.
Xu L; Lei J; Jiang D; Zhou L; Wang S; Fan W
Cancer Biol Ther; 2015; 16(12):1794-801. PubMed ID: 26529585
[TBL] [Abstract][Full Text] [Related]
9. Predicting environmental chemical factors associated with disease-related gene expression data.
Patel CJ; Butte AJ
BMC Med Genomics; 2010 May; 3():17. PubMed ID: 20459635
[TBL] [Abstract][Full Text] [Related]
10. Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors.
Neuhouser ML; Nojomi M; Baumgartner RN; Baumgartner KB; Gilliland F; Bernstein L; Stanczyk F; Ballard-Barbash R; McTiernan A
Nutr Cancer; 2010; 62(2):164-74. PubMed ID: 20099190
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
12. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
Ganz PA; Land SR
Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
[TBL] [Abstract][Full Text] [Related]
13. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
14. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
Vogel VG
Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hormone-related cancers: breast cancer.
Dunn BK; Wickerham DL; Ford LG
J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
[TBL] [Abstract][Full Text] [Related]
16. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
